Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CDK12 inhibitors(cyclin dependent kinase 12 inhibitors), CDK13 inhibitors(CHED protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H28AsClN6OS2 |
InChIKeySHJIQFGWCILYIF-HXUWFJFHSA-N |
CAS Registry2634811-35-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | CN | 20 Jul 2022 |